eli lilly gip glp-1 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both and hormone receptors - Lilly's new GLP-1 pill is

Selenium slows growth of cancer cells and protects healthy cells from DNA damage

A study has shown that up to 67% of people who stop using GLP-1 RAs regain a significant portion of the weight they lost, on average, regaining about two-thirds of their weight within a year

These prescription medications are proven to help you shed a significant amount of body fat

These insights help PlexusDx providers anticipate which individuals are more likely to experience constipation and proactively recommend dosing strategies, compounds, or complementary treatments to minimize this side effect

CJC-1295 Mechanism: CJC-1295 without DAC (Modified GRF 1-29) is a synthetic analog of growth hormone-releasing hormone with specific changes that enhance its shelf life and potency